Rapid sodium correction for hyponatremia could lead to the rare condition osmotic demyelination syndrome. Aaron Holley, MD, shares his thoughts on a 2024 study that flips this conventional wisdom.

BTSG surges with 33% infusion growth and stronger EPS gains, making it a more compelling pick than OPCH right now.

The global Infusion Pump Market is valued at USD 17.99 billion in 2024 and is projected to reach a value of USD 31.56 billion ...

New healing gadgets have been added to The Finals’ Light and Heavy classes. How will this impact gameplay and shape the meta ...

Spacelift, a leading infrastructure orchestration platform, is announcing the completion of its Series C funding round, having raised $51 million. The funding round will accelerate product innovation ...

ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...

Ten people have been effectively cured of their type 1 diabetes after a breakthrough infusion of a new treatment on the path ...

Eight individuals connected to the children's abnormal blood lead case at a kindergarten in Tianshui city, Northwest China's ...

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

Cellecor Gadgets Limited announced on July 7, 2025, that its promoters have completed a strategic stake sale, divesting 8,895 ...

Stress is a well-known trigger for cold sores. Other triggers include fatigue, sun exposure, food sensitivities and allergies ...